This federal contract award, valued at $9,842.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product, with an ultimate completion date of December 23, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen's extensive federal contract portfolio demonstrates its critical role in supplying a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other federal medical institutions.
Generated 3/21/25, 9:42 AM